biciromab brallobarbital
mAbexperimentalADC
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Fibrinogen beta chainBINDING AGENT
FGB binding agent
- FibronectinINHIBITOR
FN1 inhibitor
- Unspecified targetOTHER
Diagnostic agent
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Multi-specific
- No
- Payload
- brallobarbital
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL2109283 ↗
- ChEMBLCHEMBL2108021 ↗
Also known as
- 99mtc-besilesomab
- besilesomab
- besilesomab
- besilesomab
- besilesomab
- biciromab brallobarbital
- fibriscint
- scintimun
- scintimun
- scintimun
- t2g1s